159 related articles for article (PubMed ID: 24580121)
1. Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.
Reitter EM; Ay C; Kaider A; Pirker R; Zielinski C; Zlabinger G; Pabinger I
Clin Exp Immunol; 2014 Jul; 177(1):253-60. PubMed ID: 24580121
[TBL] [Abstract][Full Text] [Related]
2. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
[TBL] [Abstract][Full Text] [Related]
6. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.
Matsuo K; Hasegawa K; Yoshino K; Murakami R; Hisamatsu T; Stone RL; Previs RA; Hansen JM; Ikeda Y; Miyara A; Hiramatsu K; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Roman LD; Gabra H; Fotopoulou C; Sood AK
Eur J Cancer; 2015 Sep; 51(14):1978-88. PubMed ID: 26238017
[TBL] [Abstract][Full Text] [Related]
8. Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma.
Mir Seyed Nazari P; Marosi C; Moik F; Riedl J; Özer Ö; Berghoff AS; Preusser M; Hainfellner JA; Pabinger I; Zlabinger GJ; Ay C
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847343
[TBL] [Abstract][Full Text] [Related]
9. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
10. Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.
Riedl J; Posch F; Königsbrügge O; Lötsch F; Reitter EM; Eigenbauer E; Marosi C; Schwarzinger I; Zielinski C; Pabinger I; Ay C
PLoS One; 2014; 9(10):e111440. PubMed ID: 25347577
[TBL] [Abstract][Full Text] [Related]
11. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
Mandalà M; Reni M; Cascinu S; Barni S; Floriani I; Cereda S; Berardi R; Mosconi S; Torri V; Labianca R
Ann Oncol; 2007 Oct; 18(10):1660-5. PubMed ID: 17660490
[TBL] [Abstract][Full Text] [Related]
13. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
[TBL] [Abstract][Full Text] [Related]
15. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
[TBL] [Abstract][Full Text] [Related]
16. ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
Zer A; Moskovitz M; Hwang DM; Hershko-Klement A; Fridel L; Korpanty GJ; Dudnik E; Peled N; Shochat T; Leighl NB; Liu G; Feld R; Burkes R; Wollner M; Tsao MS; Shepherd FA
Clin Lung Cancer; 2017 Mar; 18(2):156-161. PubMed ID: 27913214
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N
Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967
[TBL] [Abstract][Full Text] [Related]
18. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Raskob GE; van Es N; Segers A; Angchaisuksiri P; Oh D; Boda Z; Lyons RM; Meijer K; Gudz I; Weitz JI; Zhang G; Lanz H; Mercuri MF; Büller HR;
Lancet Haematol; 2016 Aug; 3(8):e379-87. PubMed ID: 27476789
[TBL] [Abstract][Full Text] [Related]
19. Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case- Control Study in Two Community Hospitals.
Awkar N; Amireh S; Rai S; Shaaban H; Guron G; Maroules M
Pathol Oncol Res; 2018 Apr; 24(2):283-287. PubMed ID: 28470575
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]